243 related articles for article (PubMed ID: 18295427)
1. Validation of an HPLC-MS method for rociverine tablet dissolution analysis.
Hoti E; Censi R; Ricciutelli M; Malaj L; Barboni L; Martelli S; Valleri M; Di Martino P
J Pharm Biomed Anal; 2008 Jun; 47(2):422-8. PubMed ID: 18295427
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets.
Breier AR; Paim CS; Steppe M; Schapoval EE
J Pharm Pharm Sci; 2005 Aug; 8(2):289-98. PubMed ID: 16124939
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a dissolution test for rabeprazole sodium in coated tablets.
Garcia CV; Paim CS; Steppe M; Schapoval EE
J Pharm Biomed Anal; 2006 Jun; 41(3):833-7. PubMed ID: 16513316
[TBL] [Abstract][Full Text] [Related]
4. Dissolution test for citalopram in tablets and comparison of in vitro dissolution profiles.
Menegola J; Steppe M; Schapoval EE
Eur J Pharm Biopharm; 2007 Sep; 67(2):524-30. PubMed ID: 17398084
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of discriminating method of dissolution for fosamprenavir tablets based on in vivo data.
Rossi RC; Dias CL; Bajerski L; Bergold AM; Fröehlich PE
J Pharm Biomed Anal; 2011 Feb; 54(3):439-44. PubMed ID: 20943342
[TBL] [Abstract][Full Text] [Related]
6. Optimization and validation of a dissolution test for selegiline hydrochloride tablets by a novel rapid HPLC assay using a monolithic stationary phase.
Tzanavaras PD; Themelis DG; Zotou A; Stratis J; Karlberg B
J Pharm Biomed Anal; 2008 Mar; 46(4):670-5. PubMed ID: 18178360
[TBL] [Abstract][Full Text] [Related]
7. Validation of a dissolution method with HPLC analysis for lasofoxifene tartrate low dose tablets.
Space JS; Opio AM; Nickerson B; Jiang H; Dumont M; Berry M
J Pharm Biomed Anal; 2007 Sep; 44(5):1064-71. PubMed ID: 17560750
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a dissolution test method for vitamin A in dietary supplement tablets.
Davydova N; Stippler E; Jin P; Giancaspro G
J Pharm Biomed Anal; 2010 Nov; 53(3):295-301. PubMed ID: 20427140
[TBL] [Abstract][Full Text] [Related]
9. Dissolution test for lamivudine tablets: optimization and statistical analysis.
Fernandes C; Junqueira RG; Campos LM; Pianetti GA
J Pharm Biomed Anal; 2006 Nov; 42(5):601-6. PubMed ID: 16797911
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the USP dissolution test method A for enteric-coated articles by planar laser-induced fluorescence.
Miller DA; Gamba M; Sauer D; Purvis TP; Clemens NT; Williams RO
Int J Pharm; 2007 Feb; 330(1-2):61-72. PubMed ID: 17034967
[TBL] [Abstract][Full Text] [Related]
11. Optimization and validation of a dissolution test for famotidine tablets using flow injection analysis.
Tzanavaras PD; Verdoukas A; Balloma T
J Pharm Biomed Anal; 2006 May; 41(2):437-41. PubMed ID: 16413732
[TBL] [Abstract][Full Text] [Related]
12. Development and application of a validated HPLC method for the analysis of dissolution samples of gabapentin drug products.
Gupta A; Ciavarella AB; Sayeed VA; Khan MA; Faustino PJ
J Pharm Biomed Anal; 2008 Jan; 46(1):181-6. PubMed ID: 17935923
[TBL] [Abstract][Full Text] [Related]
13. Simple and reliable HPLC analysis of fexofenadine hydrochloride in tablets and its application to dissolution studies.
Oliveira DC; Weigch A; Rolim CM
Pharmazie; 2007 Feb; 62(2):96-100. PubMed ID: 17341026
[TBL] [Abstract][Full Text] [Related]
14. High performance liquid chromatographic determination of 3-methylflavone-8-carboxylic acid, the main active metabolite of flavoxate hydrochloride in human urine.
El-Gindy A; Sallam S; Abdel-Salam RA
J Pharm Biomed Anal; 2007 May; 44(1):274-8. PubMed ID: 17349765
[TBL] [Abstract][Full Text] [Related]
15. The use of HPLC/MS, GC/MS, NMR, UV and IR to identify a degradation product of eperisone hydrochloride in the tablets.
Ding L; Wang X; Yang Z; Chen Y
J Pharm Biomed Anal; 2008 Jan; 46(2):282-7. PubMed ID: 18023316
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of dissolution test for lopinavir, a poorly water-soluble drug, in soft gel capsules, based on in vivo data.
Donato EM; Martins LA; Fröehlich PE; Bergold AM
J Pharm Biomed Anal; 2008 Jul; 47(3):547-52. PubMed ID: 18403160
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a reversed-phase HPLC method for simultaneous estimation of ambroxol hydrochloride and azithromycin in tablet dosage form.
Shaikh KA; Patil SD; Devkhile AB
J Pharm Biomed Anal; 2008 Dec; 48(5):1481-4. PubMed ID: 18993009
[TBL] [Abstract][Full Text] [Related]
18. LC determination of entacapone in tablets: in vitro dissolution studies.
Paim CS; Martins MT; Malesuik MD; Steppe M
J Chromatogr Sci; 2010 Oct; 48(9):755-9. PubMed ID: 20875238
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a dissolution test for a once-a-day combination tablet of immediate-release cetirizine dihydrochloride and extended-release pseudoephedrine hydrochloride.
Likar MD; Mansour HL; Harwood JW
J Pharm Biomed Anal; 2005 Sep; 39(3-4):543-51. PubMed ID: 15975755
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a normal-phase high-performance thin layer chromatographic method for the analysis of sulfamethoxazole and trimethoprim in co-trimoxazole tablets.
Shewiyo DH; Kaale E; Risha PG; Dejaegher B; Smeyers-Verbeke J; Vander Heyden Y
J Chromatogr A; 2009 Oct; 1216(42):7102-7. PubMed ID: 19762032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
